GNH USA

Europe — EMA

Methotrexate Accord Healthcare Ireland

GNH USA supplies Methotrexate Accord Healthcare Ireland (Methotrexate), an antimetabolite for rheumatoid arthritis, psoriasis, and certain cancers.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexate Accord Healthcare Ireland, is an antimetabolite presented as a sterile solution for intra‑arterial, intramuscular and intrathecal use. It is employed to treat autoimmune disorders and certain malignancies in adult and pediatric patients.

GNH USA supplies Methotrexate Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Methotrexate used for?

Methotrexate is used across several disease families, primarily targeting rapidly dividing cells and immune modulation. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: interferes with leukemic cell proliferation. - Non‑Hodgkin lymphoma: impedes malignant lymphoid growth. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting. - Mucositis and oral ulceration. - Fatigue and weakness. - Alopecia (hair loss). - Elevated liver enzymes. - Transient rash.

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia. - Pulmonary toxicity (interstitial pneumonitis). - Severe hepatotoxicity or fibrosis. - Renal impairment or failure. - Life‑threatening infections. - Anaphylactic or severe hypersensitivity reactions.

What precautions apply to Methotrexate?

Methotrexate requires careful monitoring and patient education to mitigate risks. - Blood count monitoring: perform regular CBC to detect myelosuppression. - Liver function monitoring: assess transaminases before and during therapy. - Renal function assessment: evaluate creatinine clearance prior to dosing. - Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception. - Breastfeeding restriction: advise against nursing while on therapy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Methotrexate interact with?

Methotrexate interacts with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - NSAIDs: increase methotrexate toxicity by reducing renal clearance. - Trimethoprim‑sulfamethoxazole: potentiate myelosuppression. - Azathioprine: additive bone‑marrow suppression risk. - Live vaccines: heightened infection risk due to immunosuppression. - Proton pump inhibitors (high dose): may elevate serum methotrexate levels.

Moderate Interactions (Monitor Closely): - Penicillins: may modestly increase toxicity. - Sulfonamides: can enhance hematologic effects. - Phenytoin: may alter methotrexate metabolism. - Folic acid supplements: may reduce therapeutic efficacy. - Alcohol: exacerbates hepatic toxicity.

Frequently asked questions

What conditions is Methotrexate Accord Healthcare Ireland used for?+
Methotrexate Accord Healthcare Ireland is indicated for rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, and gestational trophoblastic disease. In each case, the drug works by inhibiting cell proliferation and modulating immune responses, helping to control disease activity and improve clinical outcomes.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting dihydrofolate to tetrahydrofolate. This interruption reduces the synthesis of purines and pyrimidines, leading to impaired DNA replication and cell division, particularly affecting rapidly dividing immune and cancer cells.
What is the usual dose of methotrexate?+
The appropriate dose of methotrexate is determined by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and treatment response. Dosage regimens vary widely, and the prescriber will tailor the schedule to each individual patient.
Is methotrexate safe to use during pregnancy or breastfeeding?+
Methotrexate is classified as pregnancy category X and is contraindicated in pregnancy because it can cause fetal malformations and loss. It is also not recommended during breastfeeding, as it may be excreted in breast milk and harm the infant. Effective contraception is required for patients of child‑bearing potential.
How do I order Methotrexate Accord Healthcare Ireland from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.
How does methotrexate compare with other antineoplastic agents?+
Methotrexate belongs to the antimetabolite class and differs from alkylating agents or taxanes by targeting folate metabolism rather than DNA cross‑linking or microtubule stabilization. This mechanism offers a distinct toxicity profile and can be combined with other chemotherapies for synergistic effect, but requires careful monitoring of hematologic and hepatic parameters.
What are the recommended storage conditions for this methotrexate product?+
Methotrexate Accord Healthcare Ireland should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly sealed to maintain product stability.
How is methotrexate administered to patients?+
Methotrexate can be given via intra‑arterial, intramuscular, or intrathecal injection, depending on the clinical indication and prescribing physician’s judgment. The route of administration is selected to achieve optimal drug delivery while minimizing systemic exposure and adverse effects.
What are the most serious risks associated with methotrexate therapy?+
Serious risks include bone‑marrow suppression leading to pancytopenia, severe hepatotoxicity or liver fibrosis, pulmonary toxicity such as interstitial pneumonitis, renal failure, and life‑threatening infections. Patients should be monitored regularly for blood counts, liver and kidney function, and any respiratory symptoms.
Who should not use methotrexate?+
Methotrexate is contraindicated in pregnant women, nursing mothers, patients with severe hepatic or renal impairment, and individuals with known hypersensitivity to methotrexate or its excipients. It should also be avoided in patients receiving live vaccines or those with uncontrolled infections.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Intraarterial Use , Intramuscular Use , Intratheca
Manufacturer
Accord Healthcare Ireland Limited
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU